Search for: "Deas v. Deas"
Results 1 - 20
of 789
Sort by Relevance
|
Sort by Date
11 Mar 2025, 9:08 am
Kendrick v. [read post]
8 Mar 2025, 5:35 pm
In United States v. [read post]
7 Mar 2025, 12:30 pm
So, we're happy to say that on April 29th the Supreme Court will hear Martin v. [read post]
6 Mar 2025, 3:11 am
” Barlow-Ahsan v. [read post]
3 Mar 2025, 7:41 pm
Puzey v. [read post]
14 Feb 2025, 12:30 pm
And in a recent case—United States v. [read post]
11 Feb 2025, 10:53 am
This schedule of drugs works much like the federal Drug Enforcement Agency’s (DEA) classification system. [read post]
10 Feb 2025, 7:27 am
DEA, a three-judge panel applied the Decker Coal doctrine in a short opinion that affirmed the DEA’s order against Dr. [read post]
3 Feb 2025, 7:30 pm
During the COVID-19 PHE, the Ryan Haight Act’s in-person medical evaluation requirement was lifted under the fourth exception, thereby allowing DEA-registered practitioners to prescribe Schedule II-V controlled substances during audio-video telemedicine encounters and certain audio-only visits without requiring a prior in-person medical evaluation. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Nov 2024, 10:05 am
(DEA) emite su tercera extensión de los beneficios de telemedicina por la pandemia. [read post]
24 Nov 2024, 6:00 am
See Page v. [read post]
21 Nov 2024, 9:33 pm
All DEA-registered practitioners may continue to prescribe via audio-visual telemedicine encounters schedule II-V controlled substances, and schedule III-narcotic controlled substances that are FDA-approved for opioid use disorder management and treatment. [read post]
21 Nov 2024, 9:05 pm
Supreme Court ruling in Securities and Exchange Commission (SEC) v. [read post]
19 Nov 2024, 2:52 pm
DEA-registered practitioners may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, if all the following conditions are met: The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice; Continue reading › [read post]
